IGF1R and cancer: In the last decade, the IGF-IR has been considered the most appropriate target to hinder IGF system deregulation in cancer, as the IGF-IR is mainly involved in survival and proliferation control, and, unlike the IR, only marginally involved in glucose regulation [8].